Dr. NIKOLAOS DRAKOULIS, MD, Professor of Clinical Pharmacology, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Greece
Born in Piraeus Greece, studied from Biochemistry at the University of Tübingen, graduated in 1986 from the Medical School of the Freie Universität Berlin (license to practice medicine). Clinical Pharmacology Lecturer (1986-1993), Clinical and Molecular Genetics specializition (1989-1991) at the Freie Universität Berlin, Pharmacoepidemiology specialization at MacGill University, Quebec, Canada (1991). Medical specialization degree in clinical pharmacology (Berlin, 1992), medical specialization degree in Clinical Chemistry (Athens, 1994) and medical specialization degree in clinical Pharmacology (Athens, 2022). University assistant at the Institute of Clinical Pharmacology (1986-1989), at the Institute of Human Genetics (1989-1991), Lecturer at the Institute of Clinical Pharmacology (1991-1993) Assistant Professor of clinical pharmacology (1993-1998), Visiting Professor of clinical pharmacology at the University of Berlin Humboldt Universität zu Berlin (1998-2000). Assistant Professor of Clinical Pharmacy and Pharmacology (2001-2019), Associate Professor of Pharmacology and Clinical Pharmacology (2019-2022) Professor of Pharmacology and Clinical Pharmacology at the National and Kapodistrian University of Athens, School of Health Sciences, Faculty of Pharmacy (2022-today) Head of Clinical Pharmacology Laboratory, (1987-1991) Head of Pharmacoepidemiology and Pharmacogenetics Laboratory, (1991-1993) at the Freie Universität Berlin, Medical director of the Pharmacogenetics Laboratory at Charité Hospital, Berlin (1993) Scientific Director of the Research Institute “Molecular Diagnostics and Biotechnology”, Athens (1993-1999) Medical Director of Greece and Cyprus at Bristol-Myers Squibb Pharmaceuticals, Athens (June 1999 – January 2000) Scientific Director of the Central Laboratory for Clinical Studies, Research Diagnostics, spin-off company of the University of Athens (2006-2011) Principal Investigator of Genomed, development genetic, genomic and Pharmacogenomic susceptibility analyses tools (2010-present) Medical Pharmacovigilance officer at HELP Pharmaceuticals, Athens (2012-2015) Scientific Consultant of iDNA of genomic and pharmacogenomic analyses (2020-present) Head of the Medical and Pharmacovigilance department at Bristol-Myers Squibb Pharmaceuticals (1999 – 2000) External expert at the Greek National Medicines Agency (2000-2001), National representative of Greece and Member at the Central Committee for Proprietary Medicinal Products Evaluation (2002-2004), Member of the European Committee Experts on Pharmacogenetics (2003 – 2008), National representative of Greece and Member of the Central Committee for the Evaluation of Medicinal Products for Human use (2004-2008) Board member of the of the Greek Society of Experimental and Clinical Pharmacology (2005-2011) Board member of the curriculum committee, Department of Pharmacy, School of Health Sciences, University of Athens (2009-2012) Board member of the Bioethics committee, Department of Pharmacy, School of Health Sciences, University of Athens (2013-present) President of the Hellenic Society of Pharmacogenomics and Personalized Diagnosis and Therapy (2014-present) Member of the National Addictive Substances Committee (2008-present) Deputy Director of the Postgraduate Program in Cosmetology-Dermatopharmacology (2020 -present) Chairman of the Special Committee for the Evaluation of applications for the issuance of a Certificate of Specialization in Clinical Pharmacology, of the Central Health Council (KESY) (2021-2023) 101 papers published in international journals (Full Publications in peer reviewed international journals), 11 chapters in books, 4 books – Impact Factor (Full publications and Published Abstracts) 366,967 – Mendeley Citation Index 3157 – Total reads 28353 – Full Text reads 4523 – h-index= 28 – i10-index 51 – PUBLICATIONS (2023);
• Papasavva, M.; Vikelis, M.; Siokas, V.; Katsarou, M.-S.; Dermitzakis, E.V.; Raptis, A.; Dardiotis, E.; Drakoulis, N. Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study. Neurol. Int. 2023, 15, 1117-1128.
• Dimitrakis E, Katsarou M, Lagiou M, Papastefanopoulou V, Spandidos DA, Tsatsakis A, Papageorgiou S, Moutsatsou P, Antoniou K, Kroupis C, Kroupis C, et al: Association of vitamin D receptor gene haplotypes with late‑onset Alzheimer’s disease in a Southeastern European Caucasian population. Exp Ther Med 24: 584, 2022
• Papasavva M, Vikelis M, Siokas V, Katsarou MS, Dermitzakis EV, Raptis A, Kalliantasi A, Dardiotis E, Drakoulis N. Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features. Front Neurol. 2023 Jan 9;13:1054333. doi: 10.3389/fneur.2022.1054333. PMID: 36698892; PMCID: PMC9868718. • Sarandi E, Krueger-Krasagakis S, Tsoukalas D, et al. Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy. Front Mol Biosci. 2023;10:1201912. Published 2023 Jun 19. doi:10.3389/fmolb.2023.1201912 • Papasavva, M.; Vikelis, M.; Siokas, V.; Katsarou, M.-S.; Dermitzakis, E.V.; Raptis, A.; Dardiotis, E.; Drakoulis, N. Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study. Neurol. Int. 2023, 15, 1117-1128. • Tsolakou A, Konstantinidis D, Economou V, Boulis S, Koutsogiannouli E, Tsioufis CP and Drakoulis N: Evaluation of the efficacy of the combination of Citrus aurantium, Cistus creticus and Olea europaea leaf extract on the lipid profiles of individuals with marginally elevated lipid levels. Int J Funct Nutr 4: 2, 2023 • Pagoni, M.; Cava, C.; Sideris, D.C.; Avgeris, M.; Zoumpourlis, V.; Michalopoulos, I.; Drakoulis, N. miRNA-Based Technologies in Cancer Therapy. J. Pers. Med. 2023, 13, 1586.

.